Patient power sets top research priorities for lichen sclerosus

   
   
People
17 Dec 2018 11:30:50.853

People with a distressing skin condition have had their say in which aspects of the disease should be prioritised in future medical research. 

Lichen sclerosus is an inflammatory skin condition affecting the genital area that causes a variety of symptoms including severe itching, pain and splitting of the skin in these sensitive areas. 

Now, a partnership led by University of Nottingham experts has revealed the top 10 questions that should be the focus of new research, according to people who have lived with this difficult to manage condition, or those that have been involved in its treatment. 

Click here for full story
 

Leading the Lichen Sclerosus Priority Setting Partnership, Dr Rosalind Simpson from the University’s Centre of Evidence Based Dermatology, said: “Despite the fact that lichen sclerosus can make life miserable for at least 1% of woman and probably similar proportion of men, this is an under-funded and under-researched medical problem. There is considerable need for further understanding of this condition as well as for improved knowledge and awareness amongst the public and the wider medical community.”

A patient who took part in the research priority setting said: “I feel honoured to have been on the steering group for this work which has given patients a rare opportunity to shape the research agenda for this little understood, yet devastating condition. I felt that my input was valued as much as that of the professionals on the group which was very empowering. I am hopeful that the findings will lead to more research in this area and ultimately to earlier diagnosis, better treatment options and perhaps even prevention of lichen sclerosis. It is very heartening to see such a focus on what is often a 'hidden' disease and I hope that the Priority Setting Partnership also raises awareness of the signs and symptoms amongst professionals and the public.”

Around 650 patients, carers, relatives or health professionals submitted more than 2,500 questions to the initial survey and additional questions were gathered from three key systematic reviews and existing guidelines in the scientific literature. Out of these, 38 unique questions were identified that had not already been answered by research. 

A second online survey, completed by 954 people, identified a shortlist of 23 most important questions. These were then discussed by a range of patients and health professionals at a face-to-face workshop at which the final ‘top 10’ Research Priorities were established. 

The Top 10 questions identified are as follows: 

  1. What is the best way to prevent and manage anatomical changes caused by lichen sclerosus?
  2. What is the best way to diagnose lichen sclerosus (diagnostic criteria)?
  3.  What surgical treatments should be offered for lichen sclerosus?
  4. Are there effective topical treatments other than topical steroids in the treatment of lichen sclerosis?
  5. What is the risk of developing cancer in patients with lichen sclerosus?
  6. Which aspects of lichen sclerosus should be measured to assess response to treatment?
  7. Can lichen sclerosus be prevented from occurring and what are the trigger factors?
  8. Is it necessary to continue treatment for patients with lichen sclerosus who do not have any symptoms and/or signs of disease activity?
  9. What is the impact on quality of life?
  10. Does the disease course of lichen sclerosus differ in boys and girls, adult males and females?

The work was carried out in collaboration with the James Lind Alliance and The British Society for the Study of Vulval Disease, which also funded the work. The full report is now available online and has also been published as a research paper in the British Journal of Dermatology. The work also highlighted a lack of general knowledge and awareness of lichen sclerosis among health professionals and the wider public.

 

— Ends —

Our academics can now be interviewed for broadcast via our Media Hub, which offers a Globelynx fixed camera and ISDN line facilities at University Park campus. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email  pressoffice@nottingham.ac.uk or see the Globelynx website for how to register for this service.

For up to the minute media alerts, follow us on Twitter

Notes to editors: 

The University of Nottingham is a research-intensive university with a proud heritage, consistently ranked among the world's top 100. Studying at the University of Nottingham is a life-changing experience and we pride ourselves on unlocking the potential of our 44,000 students - Nottingham was named both Sports and International University of the Year in the  2019 Times and Sunday Times Good University Guide, was awarded gold in the TEF 2017 and features in the top 20 of all three major UK rankings. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement. We are ranked eighth for research power in the UK according to REF 2014. We have six beacons of research excellence helping to transform lives and change the world; we are also a major employer, proud of our Athena SWAN silver award, and a key industry partner- locally and globally.

 

Story credits

More information is available from Dr Rosalind Simpson,Centre of Evidence Based Dermatology, Faculty of Medicine and Health Sciences on +44 (0) 115 82 32436 or email Rosalind.simpson@nottingham.ac.uk
EmmaRayner2

Emma Rayner - Media Relations Manager

Email: emma.rayner@nottingham.ac.uk Phone: +44 (0)115 74 84413  Location: University Park

Additional resources

No additional resources for this article

Media Relations - External Relations

The University of Nottingham
C Floor, Pope Building (Room C4)
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5798
email: pressoffice@nottingham.ac.uk